Park Medi World schedules September investor and analyst meetings

1 min read | Published on 05 Sept 2026, 05:30 PM |Updated on 05 Sept 2026, 05:30 PM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

Key Highlights

Park Medi World scheduled four investor meetings in September 2026
Two physical events planned with Kotak and Anand Rathi in Mumbai
Virtual group meetings set with Kotak Securities and Arihant Capital
Company confirmed no unpublished price-sensitive info will be shared

*this image is generated using AI for illustrative purposes only.

Park Medi World Limited has disclosed a schedule of upcoming meetings with analysts and investors for September 2026. The company will participate in four events, combining physical and virtual formats to engage with stakeholders.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management representatives will attend these conferences to discuss the company’s performance and outlook.

Meeting Schedule

The company has outlined specific dates, venues, and modes for each engagement. The first two meetings are scheduled as physical events in Mumbai, while the subsequent two will be conducted virtually.

Date	Event	Mode	Type
September 17, 2026	Kotak Healthcare Forum	Physical	One on one & Group Meetings
September 21, 2026	Anand Rathi Annual Flagship Conference G-200 Summit 2026	Physical	One on one & Group Meetings
September 23, 2026	Kotak Securities Investor Meeting	Virtual	Group Meetings
September 28, 2026	Arihant Capital: Bharat Connect Conference- Rising Stars	Virtual	Group Meetings

Key Details

The physical meetings are set to take place at specific locations in Mumbai. The Kotak Healthcare Forum will be held at Kotak Securities Limited in Bandra starting at 12:00 pm. The Anand Rathi summit is scheduled at Taj Santacruz from 11:00 am onwards.

The virtual engagements on September 23 and September 28 will also begin at 11:00 am and 12:00 pm respectively. The company noted that the schedule is subject to change due to exigencies on the part of investors or the company.

Regulatory Compliance

Park Medi World emphasized that its representatives do not intend to discuss any unpublished price-sensitive information during these meetings. This assurance aligns with standard regulatory practices to prevent information asymmetry among investors.

The full disclosure is available on the company’s website at parkhospital.in. The notice was signed by Abhishek Kapoor on behalf of the company.

Historical Stock Returns for Park Medi World

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.16%	-1.34%	-0.81%	+50.24%	0.0%	0.0%

How might the outcomes of these September 2026 investor meetings influence Park Medi World's stock valuation in the immediate quarter?

What specific strategic initiatives or expansion plans is management likely to highlight to attract institutional interest at the Anand Rathi G-200 Summit?

Could the shift towards virtual engagements for later dates signal a broader trend in how healthcare firms manage investor relations costs and reach?

Park Medi World

View Company Insights

View All News

Park Medi World shareholders approve amendment to IPO proceeds usage

2 min read | Published on 04 Sept 2026, 02:43 PM |Updated on 04 Sept 2026, 02:43 PM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

Key Highlights

Shareholders approve special resolution to amend IPO proceeds usage via postal ballot
Resolution passes with 99.99% support, totaling 39.5 crore votes in favor
Promoters and public institutions vote unanimously in favor of the proposal
Public non-institutional participation stands at 0.22%, contributing all dissenting votes

*this image is generated using AI for illustrative purposes only.

Park Medi World Limited shareholders have approved a special resolution to amend certain objects of its Initial Public Offer (IPO) proceeds. The resolution was passed via postal ballot on September 3, 2026, receiving near-unanimous support across investor categories.

The voting process concluded with 39,51,47,456 votes cast in favor of the resolution, representing 99.99% of the total votes polled. Only 3,919 votes were recorded against the proposal. The company had a total of 43,19,30,864 equity shares outstanding as of the record date, July 31, 2026.

Voting Breakdown by Investor Category

Promoter and promoter group shareholders demonstrated complete alignment with the management's proposal. The promoters hold 35,80,48,507 shares and voted 100% in favor of the resolution. Public institutional investors also showed strong support, casting 3,70,54,428 votes in favor out of 5,20,24,295 shares held, resulting in a 71.23% participation rate among this group.

Category	Shares Held	Votes Polled	Votes In Favor	Votes Against	% In Favor
Promoter Group	35,80,48,507	35,80,48,502	35,80,48,502	0	100.00%
Public Institutions	5,20,24,295	3,70,54,428	3,70,54,428	0	100.00%
Public Non-Institutions	2,18,58,062	48,445	44,526	3,919	91.91%
Total	43,19,30,864	39,51,51,375	39,51,47,456	3,919	99.99%

Process Compliance

The postal ballot process was conducted through e-voting only, in compliance with Ministry of Corporate Affairs (MCA) circulars and Regulation 44 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Deepak Sharma of Sharma Jain & Associates served as the independent scrutinizer for the vote.

The e-voting window opened on August 5, 2026, at 9:00 am and closed on September 3, 2026, at 5:00 pm. The scrutinizer confirmed that the voting system provided by National Securities Depository Limited (NSDL) functioned securely and that all procedural requirements under Section 108 and 110 of the Companies Act, 2013, were met.

What the Numbers Show

The voting pattern reveals a distinct divergence between institutional and retail participation levels. While promoter and public institutional investors achieved high engagement rates—with promoters voting nearly all their holdings and institutions participating at over 71%—public non-institutional investors recorded a participation rate of just 0.22%. Despite this low turnout from retail shareholders, the dissenting votes originated entirely from this segment, accounting for all 3,919 negative votes cast.

The resolution is deemed passed as it secured the requisite majority. The detailed voting results and scrutinizer’s report are available on the company’s investor relations website.

Historical Stock Returns for Park Medi World

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.16%	-1.34%	-0.81%	+50.24%	0.0%	0.0%

What specific new projects or strategic initiatives will Park Medi World fund with the amended IPO proceeds, and how might this shift impact its long-term revenue growth?

How will the significant divergence in participation rates between institutional investors (71.23%) and retail shareholders (0.22%) influence future investor relations strategies and market perception?

Could the unanimous support from promoters and institutions signal an upcoming change in corporate governance or management structure that retail investors should monitor?

Park Medi World

View Company Insights

View All News